{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21124 Clinical effectiveness policy 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "CLINICAL EFFECTIVENESS POLICY"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21124"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "02 July 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "01 July 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Clinical Effectiveness, NICE, NCEPOD, MBRRACE"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "NICE and National Confidential Enquiries (NCEPOD, MBRRACE-UK)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12, 17"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Clinical Effectiveness"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Manori Jayasekera"
                    },
                    {
                        "text": "NICE Guidance and National Audit Facilitator, BTUH"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Clinical Audit and Effectiveness Group (virtual ratification)"
                    },
                    {
                        "text": "28 June 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dr David Walker"
                    },
                    {
                        "text": "Chief Medical Officer"
                    },
                    {
                        "text": "21 June 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "29 June 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "August 21"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21124 Clinical effectiveness policy 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 8,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Dr David Gertner"
                    },
                    {
                        "text": "Lead for Clinical Effectiveness"
                    },
                    {
                        "text": "24 May 2021"
                    },
                    {
                        "text": "Tracy Turner"
                    },
                    {
                        "text": "Associate Director Risk & Compliance"
                    },
                    {
                        "text": "03 June 2021"
                    },
                    {
                        "text": "Helen Clarke"
                    },
                    {
                        "text": "Associate Director Patient Safety"
                    },
                    {
                        "text": "03 June 2021"
                    },
                    {
                        "text": "Nick Irwin"
                    },
                    {
                        "text": "Clinical Audit Manager, SUH"
                    },
                    {
                        "text": "28 May 2021"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Head of Pharmacy, SUH"
                    },
                    {
                        "text": "03 June 2021"
                    },
                    {
                        "text": "Evelyn Allen"
                    },
                    {
                        "text": "Chief Pharmacist"
                    },
                    {
                        "text": "15 June 2021"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Medication Safety Officer"
                    },
                    {
                        "text": "15 June 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Group if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Clinical Audit and Effectiveness Group (virtual ratification)"
                    },
                    {
                        "text": "28 June 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) MSEPO-20242 Risk management strategy MSEPO-21092 Risk Management policy and procedure MSEPO-20245 Policy for the introduction of new interventional procedures"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/ Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Manori Jayasekera"
                    },
                    {
                        "text": "02 July 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Implementation and monitoring of guidance from the national institute for health and care excellence."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust ...................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Procedure ..................................................................................................................... 9"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Training requirements ................................................................................................. 16"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Monitoring and audit ................................................................................................... 16"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Approval and implementation ..................................................................................... 17"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Equality impact assessment ....................................................................................... 17  References ................................................................................................................. 17 APPENDIX 1: implementation flow chart for nice guidelines and quality standards .......... 18 Appendix 2: Preliminary equality analysis .......................................................................... 19"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "The National Health Service aspires to the highest standards of excellence and professionalism in the provision of high quality care (NHS Constitution, Department of Health and Social Care, 2021). In line with Lord Ara Darzi's definition of quality, as set out in \u2018High Quality Care for All: NHS Next Stage Review Final Report' (2008), this principle explains that quality in healthcare is focused across three dimensions:"
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Effectiveness of Care"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient Safety"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient Experience"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Over  the  last  few  years,  there  have  been  significant  developments  that  have identified the need to ensure NHS Trusts measure, review and improve quality."
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The NHS Constitution for England (Department of Health and Social Care, 2021) establishes the principles and values of the NHS in England; principles that direct the NHS in the provision of care that is accessible in addition to being clinically and cost effective."
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "This is to provide a structure through which best practice guidance (in particular NICE guidance and findings from National Confidential Enquires) is considered, and where applicable, implemented within the Trust. Relevant best practice guidance published  from  known  and  approved  sources  is  disseminated  from  a  central infrastructure through a recognised route for implementation by a nominated clinical lead/group."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "type": "table",
            "sequence_num": 28,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Term"
                    },
                    {
                        "text": "Definition"
                    },
                    {
                        "text": "Clinical Effectiveness"
                    },
                    {
                        "text": "The extent to which specific clinical interventions, when deployed in the field for a particular patient or population, do what they are intended to do (NHS Executive, 1996) i.e. maintain and improve health and secure the greatest possible health gain from the available resources. To be reasonably certain that an intervention has produced health benefits, it needs to be shown to be capable of producing worthwhile benefit (efficacy and cost effectiveness) and has produced that benefit in practice It is about doing the right thing in the right way, for the right patient at the right time, which involves getting evidence of what works into everyday practice and evaluating its effect in patient care. The right thing relates to evidence based practice. The right way relates to skills and competence."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 29,
            "data": {
                "num_rows": 12,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "At the right time relates to providing treatment/services when the patient needs them."
                    },
                    {
                        "text": "Cost Effectiveness"
                    },
                    {
                        "text": "The ratio of the costs of healthcare to the health outcomes of a particular form of healthcare (NHS Executive, 1996)."
                    },
                    {
                        "text": "National Institute for Health and Care Excellence (NICE)"
                    },
                    {
                        "text": "NICE are responsible for providing national guidance on promoting good health and preventing and treating ill health in line with the best available evidence of clinical and cost effectiveness for England & Wales."
                    },
                    {
                        "text": "NICE Guidance"
                    },
                    {
                        "text": "A term used in this policy to include Technology Appraisal Guidance, NICE Guidelines, Quality Standards, Interventional Procedure Guidance, and Medical Technologies Appraisal Guidance."
                    },
                    {
                        "text": "Technology Appraisal Guidance (TAs)"
                    },
                    {
                        "text": "Technology Appraisal guidance are recommendations on the use of new and existing medicines and treatments within the NHS and the only NICE guidance where compliance is mandatory. The NHS is legally obliged to fund and resource medicines and treatments recommended by NICE's technology appraisals."
                    },
                    {
                        "text": "Interventional Procedure Guidance (IPGs)"
                    },
                    {
                        "text": "Interventional Procedure Guidance evaluates the safety and efficacy of such procedures."
                    },
                    {
                        "text": "NICE Guidelines (NGs)"
                    },
                    {
                        "text": "Evidence-based recommendations on a wide range of topics, from preventing and managing specific conditions, improving health and managing medicines in different settings, to providing social care to adults and children, and planning broader services and interventions to improve the health of communities. NGs also cover previously published clinical guidelines, cancer service guidelines, public health guidelines, social care guidelines, medicines practice guidelines and safe staffing guidelines."
                    },
                    {
                        "text": "Medical Technologies Appraisal Guidance (MTGs)"
                    },
                    {
                        "text": "Guidance issued by NICE evaluating new or innovative medical technologies (including devices and diagnostics), as selected by the Medical Technologies Advisory Committee."
                    },
                    {
                        "text": "Quality Standards (QSs)"
                    },
                    {
                        "text": "A set of specific, concise statements and associated measures. They set out aspirational, but achievable, markers of high-quality, cost- effective patient care, covering the treatment and prevention of different diseases and conditions"
                    },
                    {
                        "text": "Baseline Assessments"
                    },
                    {
                        "text": "Baseline assessment tools can be used to evaluate current practice and plan activity to meet the recommendations. These provide help with understanding the current status of compliance and conducting improvement initiatives."
                    },
                    {
                        "text": "Confidential Enquiry"
                    },
                    {
                        "text": "An enquiry designed to improve healthcare standards by collecting data, identifying any shortfalls in the care provided and devising recommendations to improve future care. They are confidential in the sense that the details of the patient/hospital/involved clinicians remain anonymous."
                    },
                    {
                        "text": "National Confidential Enquiry into"
                    },
                    {
                        "text": "NCEPOD's purpose is to assist in maintaining and improving standards of care for adults and children by reviewing the management of patients, undertaking confidential surveys and"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 30,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Patient Outcome and Death (NCEPOD)"
                    },
                    {
                        "text": "research, and by publishing the results of such activities."
                    },
                    {
                        "text": "Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK)"
                    },
                    {
                        "text": "The programme investigates the deaths of women and their babies during or after childbirth, and also cases where women and their babies survive serious illness during pregnancy or after childbirth. The aim is to identify avoidable illness and deaths so the lessons learned can be used to prevent similar cases in the future leading to improvements in maternal and newborn care for all mothers and babies."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "MSE NICE Implementation Group (NIG) has the responsibility to consider the implication of NICE Guidance and to provide advice on managing implementation. NIG is responsible for monitoring compliance to NICE guidance and reporting to the Risk and Compliance Group and the Clinical Audit and Effectiveness Group. Where issues  of  non-compliance  are  identified,  the  NIG  will  review  and  agree  that appropriate action is being taken to return to compliance."
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "MSE Clinical Audit and Effectiveness Group (CAEG) is responsible for receiving reports on compliance from NIG by exception reporting and provides assurance to the Board of Directors via the Quality Governance Committee that the Trust is compliant with relevant external best practice standards."
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "Risk and Compliance Group (RCG) will review and approve changes in clinical practice based on the local implementation of best practice guidance both directly and indirectly through a reporting group. The RCG will monitor compliance to this policy through quarterly reports from NIG."
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "Medicines  Assurance  Group  (MAG)  provides  multidisciplinary  leadership  and governance for clinical and cost-effective use of medicines across the Trust. It is responsible for monitoring and reviewing current and new practices in management of  medicines  in  response  to  alerts/  recommendations/instruction  from  external agencies. It supports the Trust in the new entry of medicines onto the formulary which fall outside the remit of Mid & South Essex Health and Care Partnership Medicines Optimisation Committee (MSEMOC) e.g. drugs commissioned by NHS England."
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.5,
                "text": "Care Group / Divisional Clinical Governance Groups will nominate clinical leads for the implementation, reporting and monitoring of best practice guidance from sources other than NICE guidance and will implement decisions made by NIG. The Groups are also responsible for monitoring the implementation of NICE Guidance within the Division and ensuring that priority clinical audits relating to NICE guidance are considered for inclusion in Divisional Clinical Audit Programmes."
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "Chief Executive as the Trust's Accountable Officer has overall responsibility for the quality and safety of services provided by the Trust. In this respect, he/she is responsible for ensuring that the infrastructure required for supporting the delivery and implementation of this document is available. He/she has delegated the full implementation of this document to the Chief Medical Officer and Chief Nursing Officer."
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.7,
                "text": "Chief Medical Officer is responsible for ensuring that the necessary systems and processes are available to ensure that all medical staff are able to comply with the contents of this policy."
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "Chief Nursing Officer is responsible for ensuring that the necessary systems and processes are available to ensure that all non-medical staff (nurses, midwives and"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 1,
                "text": "allied health professionals) are able to comply with the contents of this policy. 4.9  Lead for Clinical Effectiveness is responsible for the strategic development of clinical effectiveness activities and supporting clinicians in the review, implementation and monitoring of these activities."
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "As Chair of NIG, he/she is also responsible for promoting the implementation of NICE guidance and the production of reports on the progress made with implementing NICE guidance."
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Lead for Clinical Audit is responsible for receiving reports on the progress of clinical audits against NICE guidance which contribute to an effective clinical audit programme in the Trust."
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.11,
                "text": "Chief Pharmacist is responsible setting the overall framework and policy standards for providing information and interpretation to healthcare professionals on the use of medicines relating to clinical effectiveness. They ensure monitoring process exists and functions to assure that decisions relating to medicines management are made in accord with local and national protocols. These are aligned with the remit of the MSE Medicines Assurance Group."
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Chief Pharmacist delegates this responsibility to the designated site Pharmacy Head of Department for MSE Medicines Optimisation for delivery."
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.12,
                "text": "Pharmacy Head of Department (HoD) for MSE Medicines Optimisation (hosted by Basildon HoD) is responsible for ensuring all medicines TAs are considered at Medicines Assurance Group at the next meeting following issue by NICE. They will ensure a written record of the implementation status of each medicine TA is maintained supported by the relevant specialty clinical lead/director. As professional secretary of MAG, they will ensure each medicines TA and compliance status is published on the Trust intranet and internet within 3 months of the date of issue by NICE. They will provide information of compliance to NIG on a quarterly basis."
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.13,
                "text": "Medical Directors, Clinical Directors and Directors of Nursing and Midwifery are responsible for ensuring that all staff in their Divisions adhere to the requirements set out in this policy and that there are appropriate nominated staff and working groups to implement relevant national and local best practice guidance."
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Clinical Director will, if required, respond to cases of non-compliance where it is requested. They will also present information requesting financial support to the appropriate investment group where this is required to implement change."
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.14,
                "text": "Divisional General Managers are responsible for ensuring that the implementation of best practice guidance is supported, monitored and progress of actions plans are reported to Divisional Clinical Governance Groups."
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.15,
                "text": "Designated Clinical Leads are responsible for ensuring that all relevant staff are aware of the best practice guidance. They will set up and chair an implementation working group (if required) ensuring that all relevant professional groups are represented."
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Leads will ensure that a baseline assessment is carried out to identify the differences between current practice and published recommendations and where required, ensure that an implementation plan is developed and submitted to the appropriate Divisional Clinical Governance Group for review and approval. This information will also be sent to the Clinical Effectiveness Unit at regular intervals as requested. Upon implementation, the lead should ensure that local clinical guidelines are adjusted accordingly."
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where implementation requires financial support not otherwise agreed, the Lead will provide the appropriate Divisional Clinical Director with a proposal to present to the appropriate investment group. Where this relates to NICE guidance, this proposal will also be presented to the NICE Implementation Group for information and support."
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.16,
                "text": "Divisional Clinical Governance Facilitators are responsible for the provision of reports on compliance and exceptions at agreed intervals to the Care Group/Divisional Clinical Governance Group and to the Risk and Compliance Group. Where non-compliance is identified, they would support the designated Clinical Lead in completing a risk assessment and the information will be presented to the Clinical Governance Group and to the Clinical Effectiveness Team."
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.17,
                "text": "All healthcare professionals are responsible for keeping up to date with current best practice in their specialty areas, for supporting the implementation of best practice guidance and seeking approval for change in practice if this is required."
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.18,
                "text": "Local Reporters for Confidential Enquiries NCEPOD  are responsible for compiling and sending datasets requested for NCEPOD studies and providing local assistance in contributing to the studies."
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Requests updates from designated clinical leads on progress with active studies and progress with the development and implementation of plans against NCEPOD recommendations."
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.19,
                "text": "Trust NCEPOD Ambassador provides support to the NCEPOD local reporters by encouraging colleagues to complete questionnaires and implement NCEPOD recommendations."
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "The Trust links with MBRRACE-UK through staff in the Division of Women & Children for active reporting by designated local appointees for maternal deaths, stillbirths and infant death and also for the receipt of publications."
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Designated staff assigned to lead the implementations produce progress reports for the Divisional Clinical Governance Group."
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.21,
                "text": "Clinical Effectiveness Team Line Manager is responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "the  development  of  clinical  effectiveness  processes  across  the  Trust including the setting of strategic objectives and the production of plans to implement these."
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "the  operational  management  of  the  support  functions  for  clinical effectiveness"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.22,
                "text": "Clinical Effectiveness Staff will:"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "maintain the Trust's repository of clinical effectiveness information in an appropriate  medium  depending  on  source  submission,  access  and copyright."
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "disseminate information as dictated by its source and content and in compliance to Trust procedure."
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "maintain a database of information relating to the implementation of NICE guidance."
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "provide monitoring reports relating to clinical effectiveness as requested and support the publication of the Clinical Effectiveness Annual Report."
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "provide information as evidence for compliance against various external standards  (such  as  the  Care  Quality  Commission  Registration Requirements  and  the  National  Health  Service  Litigation  Authority Standards)."
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Procedure"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "The Clinical Effectiveness Framework (NHS Executive, 1996) has targets of good practice for the Trust that conforms to three main functions of inform, change and monitor and this forms the basis of the Clinical Effectiveness Procedure."
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "In order to change practice, NICE (Into practice guide, 2018) recommends that individuals need to identify and understand the barriers to change and who it affects in order to develop strategies and practical solutions to overcome them to effectively implement a new policy or guidance."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "A generic traffic lighting system is used for reporting purposes of compliance to NICE recommendations as follows:"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "type": "table",
            "sequence_num": 72,
            "data": {
                "num_rows": 6,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Key for assessment"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "*No progress made towards implementation"
                    },
                    {
                        "text": "RED"
                    },
                    {
                        "text": "**Clinical lead nominated and working towards baseline assessment or <50% compliant"
                    },
                    {
                        "text": "AMBER 1"
                    },
                    {
                        "text": "Baseline assessment / action plan in place and 50 \u2013 74% compliant"
                    },
                    {
                        "text": "AMBER 2"
                    },
                    {
                        "text": "Good progress to full implementation (75 to 99% compliant)"
                    },
                    {
                        "text": "AMBER 3"
                    },
                    {
                        "text": "Fully compliant and any identified exceptions with risk assessments"
                    },
                    {
                        "text": "GREEN"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "*Clinical Lead is not confirmed within 6 weeks of the NICE publication **Baseline assessment should be completed within 3 months of publication; if a baseline assessment is not completed within 3 months, exception reporting will be activated."
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Milestones are set to track progress towards full implementation of NICE guidelines and quality standards. The milestones that should be achieved are as follows:"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Within 1st year - Amber 1"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Within 2nd year - Amber 2"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Within 3rd year - Amber 3"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "After 3 years - full compliance"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "Exception reporting is activated where no progress has been made towards implementation (red traffic light) or where implementation milestones have not been achieved."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.6,
                "text": "NICE Guidance"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The type of guidance determines the exact process for monitoring implementation."
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.6.1 NICE Guidelines (NG) and Quality Standards (QS) The underlying principles for NGs and QSs are similar (see flowchart in Appendix I)."
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.6.2 Identifying relevant documents"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NICE publishes a forward planner of guidance in development with an expected publication date. The forward planner is updated monthly."
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "On a quarterly basis, clinical effectiveness staff will review the NICE forward planner (i.e. horizon scanning) to identify guidance due to be published in the next 3 months and in conjunction with the Lead for Clinical Effectiveness, the Divisional/Speciality Clinical Director will be requested to nominate the most appropriate clinician to review the NICE consultation document."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The nominated Clinical Lead is asked to comment on the potential implications for the Trust and may also be able to register interest with NICE to comment on the document."
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NICE publish its guidance on a monthly basis and clinical effectiveness staff will receive automated newsletters from NICE alerting them of the guidance that has been published."
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.6.3 Inform \u2013 Dissemination of documents"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Following the publication of NICE Guidance, the new releases are posted on the Trust intranet sites."
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If not already nominated, the Lead for Clinical Effectiveness as Chair of the NICE Implementation Group will identify the most appropriate clinician (taking into consideration existing allocation of Clinical Leadership for NICE Guidance) to be invited to lead on implementation (where required)."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Within 1 month of publication, the clinical effectiveness staff will send a baseline assessment template to the Clinical Lead reflecting the NICE recommendations to obtain the following information:"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "relevance of the recommendations to the Trust/hospital site"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "the current status of compliance to the guidance"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "action plan for implementation (if required)"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "monitoring arrangements for implementation and clinical audit"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The request will be copied to the Divisional Clinical Director, Head of Nursing, General Manager and Clinical Governance Facilitator as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The information received will be collated and stored on the Trust Clinical Effectiveness NICE database."
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.6.4 Change \u2013 Gap analysis and action planning"
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Within three months of publication, the lead clinician with responsibility for the implementation will consider the guidance and ensure that a baseline assessment of current practice is carried out to determine compliance. Any gaps in the service should be highlighted and an implementation plan developed to support changes in practice that are required (NICE costing tools can be used where cost implications are likely). Where the scope of guidance is wide, consideration should be given to the establishment of an implementation group; however the responsibility will remain with the identified Clinical Lead."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where a decision is made not to implement NICE recommendations or the current situation makes implementation impossible, this should be clearly documented on the baseline assessment tool, including the reasons and the Divisional Clinical Governance Group informed and placed on the Divisional Risk Register. This will be reported to the NIG for acknowledgement."
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Local clinical guidelines should be developed or updated where required to support the implementation of NICE guidance accordingly."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For newly published Guidelines and QSs, the clinical lead will be expected to present the implementation plan to the appropriate Divisional Clinical Governance Group for review and approval. Progress of implementation of the identified actions should be monitored at monthly Divisional Governance Meetings."
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Implementation plans will be monitored by clinical effectiveness staff every 6 months for NGs and QSs to ensure that recommendations are acted upon and progress towards full implementation is being maintained. The current status of implementation and any associated outstanding actions will also be reported quarterly in Divisional Risk and Compliance Exception Reports and to NIG."
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.6.5 Monitor"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Risk and Compliance Group monitors the implementation of NICE Guidance through exception reports from Divisional and Clinical Effectiveness reports."
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Risks associated with non-compliances should be placed on Divisional Risk Registers as identified in the Risk Management Procedure and the Risk Management Strategy."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Evidence from national or local clinical audit will be considered to inform the implementation and where requirement for improvement is identified, will be placed on the Divisional Audit and QI programmes as priority."
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.7,
                "text": "Technology Appraisal Guidance (TAs)"
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The NHS is legally obliged to fund and resource medicines and treatments recommended by NICE's technology appraisals (NICE, 2014). The NHS Constitution states that patients have the right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate."
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "text": "When NICE recommends a treatment 'as an option', the NHS must make sure it is available within 3 months (unless otherwise specified) of its date of publication. The Trust must implement TAs within these timescales set by NICE. The Medicines Assurance Group (MAG) will review the TA and ensure full implementation, as appropriate. Pharmacy Head of Department (HoD) for MSE Medicines Optimisation (responsibility for TAs) will provide information of compliance to NIG on a quarterly basis. Trust Clinical Effectiveness database will maintain a record of the TA compliance as reported to NIG."
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Any non-compliance will be reported to NIG and escalated through MAG to Risk & Compliance Group."
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.8,
                "text": "Interventional Procedure Guidance (IPG)"
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.8.1 Identifying relevant documents"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Following the publication of NICE IPGs, the clinical effectiveness staff in conjunction with the Lead for Clinical Effectiveness will determine the specialty to which the guidance is relevant. For detailed information regarding IPGs, refer to the Policy for the Introduction of New Interventional Procedures."
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.8.2 Inform \u2013 Dissemination of documents"
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The clinical effectiveness staff will, on behalf of the Lead for Clinical Effectiveness, request the relevant Divisional/Speciality Medical/Clinical Directors to inform if the procedure is already being performed in the Trust or not and if being performed, to confirm compliance to NICE recommendations. They are required to respond within 2 weeks. One reminder is sent after 2 weeks."
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where no response is received, this will be escalated to R&CG as an exception. Trust Clinical Effectiveness database will maintain a record of IPG compliance."
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where non-compliance is reported, Divisional/Clinical Directors will be expected to disseminate this information to the relevant Clinical Governance Group for consideration of a risk assessment and inclusion in the Risk Register as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Any non-compliance to NICE IPGs will be exception reported to NIG and to the Clinical Audit and Effectiveness Group."
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.8.3 Change \u2013 Gap analysis and action planning"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where a clinician has indicated interest in introducing a new interventional procedure, the full approval process will be followed as detailed in the Trust Policy for the Introduction of New Interventional Procedures."
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.8.4 Monitor"
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Newly published IPGs and their current status in the Trust are reported to the Divisional Clinical Governance Groups quarterly via the Clinical Audit and Effectiveness reports."
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All risks associated with non-compliances should be placed on Divisional Risk Registers as identified in the Risk Management Procedure and the Risk Management Strategy."
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.9,
                "text": "National Confidential Enquires"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The National Confidential Enquiries are independent bodies who identify projects that investigate issues in different care settings. These enquiries are designed to help assess the quality of healthcare, and stimulate improvement in safety and effectiveness by systematically enabling clinicians, managers and policy makers to learn from adverse events and other relevant data. The two confidential enquiries relevant to the Trust are:"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) which reviews the standards of care for adults and children through confidential surveys making recommendations aimed at improving care"
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Maternal, Newborn and Infant Clinical Outcomes Review Programme which incorporates the Confidential Enquiries into Maternal Deaths (CEMD, established in 1952). CEMD is recognised as having led to major improvements in the health and care of women and their babies. In 2012 MBRRACE-UK (Mothers and Babies \u2013 Reducing Risk through Audits and Confidential Enquiries across the UK) was appointed to run the national Maternal, Newborn and Infant Clinical Outcomes Review Programme. The aim is to identify avoidable illness and deaths so the lessons learned can be used to prevent similar cases in the future leading to improvements in maternal and newborn care for all mothers and babies."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.9.1  The National Confidential Inquiry into Suicide and Safety in Mental Health (NCISH) considers all instances of suicide and homicide that occur within Mental Health Services in the UK. Although the focus is on mental health services, the Trust must consider the implications for acute services where this is applicable."
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.1,
                "text": "National Confidential Enquiry into Patient Outcome and Death (NCEPOD)"
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.10.1 Participation in studies"
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The NCEPOD Local Reporter acts as the Trust link for receiving information regarding NCEPOD studies and will facilitate the compilation of datasets requested by NCEPOD. Information regarding future studies is discussed with the Lead for Clinical Effectiveness on behalf of the Medical Director who will nominate a clinical lead."
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The clinical effectiveness staff provides administrative support to clinicians participating in studies and collates information required for the studies ensuring that this information is submitted to NCEPOD by published deadlines."
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.11,
                "text": "NCEPOD Reports"
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.11.1 Inform"
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Early notification of the publication of NCEPOD reports will be received by the NCEPOD Local Reporter who will bring this to the attention of the Lead of Clinical Effectiveness, the Medical Director and the nominated clinical lead."
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.11.2 Change \u2013 Gap analysis and action planning"
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Following publication of the studies, the clinical lead will be asked to consider the findings and recommendations from the report and ensure that a self-assessment (organisational gap analysis) is conducted to identify differences between current practices and published key recommendations and identify any cost implications of change."
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The clinical lead will ensure that an implementation plan is developed to support any changes in practice and where required, produce proposals for financial support. Where a decision is made not to implement NCEPOD recommendations or the current situation makes implementation impossible, the decision should be clearly documented on the self-assessment and recorded on the appropriate risk register."
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The clinical lead will work in conjunction with appropriate Divisional Clinical Directors to ensure the plan is implemented. Clinical Directors will present proposals for financial support as required."
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.11.3 Monitor"
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Participation in studies and progress with the implementation of agreed actions will be reported to the Clinical Audit and Effectiveness Group."
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Nominated clinical leads should present an update on progress with implementation against agreed milestones. Lack of progress with implementation will be highlighted to the Lead for Clinical Effectiveness for action."
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All risks associated with non-compliance should be placed on Divisional Risk Registers as identified in the Risk Management Procedure and the Risk Management Strategy."
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.12,
                "text": "Mothers and Babies - Reducing Risk through Audits and Confidential Enquiries across the UK (MBBRACE-UK)"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.12.1 Participation in studies"
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Healthcare Quality Improvement Partnership (HQIP) appointed MBRRACE-UK to conduct the national Maternal, Newborn and Infant Clinical Outcomes Review Programme. Reporting arrangements to MBRRACE- UK will continue to be undertaken by separate designated local appointees within the Maternity and Paediatric services."
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 0,
                "text": "On the publication of Confidential Enquiry reports local co-ordination is undertaken by the Head of Midwifery with local appointees taking the implementation lead role as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.13,
                "text": "MBRRACE-UK Reports"
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.13.1 Inform"
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The publication of the report, its findings and recommendations will be presented at the next available Divisional Clinical Governance Group (CGG) meeting and RCG via the Divisional exception reports."
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The clinical lead for the implementation will also present a summary report to CGG of the findings and recommendations at an agreed time, setting out a proposed implementation timetable."
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.13.2 Change"
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The clinical lead will undertake a baseline audit to identify differences between current practices and published key recommendations and identify cost implications of change."
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "text": "An action plan will be produced to support any changes in practice that are required with identified responsibility for implementation, clearly defined timescales and where required, produce proposals for financial support."
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The clinical lead will work in conjunction with appropriate staff in the Division to ensure the action plan is implemented. The Clinical Lead for Obstetrics will present proposals for financial support as required."
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 1,
                "text": "5.13.3 Monitor"
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The clinical lead should present an update on progress with implementation against agreed milestones annually to CGG with 6 monthly Exception Reports using the traffic light system."
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 1,
                "text": "All risks associated with non-compliance should be placed on Divisional Risk Registers as identified in the Risk Management Policy and the Risk Management Strategy."
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.14,
                "text": "Royal Colleges and Professional Bodies"
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Many Royal Colleges and Professional Bodies have formed Clinical Effectiveness Units in order to produce clinical effectiveness information for the use of their members and to add to the general pool of clinical effectiveness information in the United Kingdom. Where this is outside the commissioning remit of NICE the following process should be followed."
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.14.1 Clinicians (or equivalent professionals) in receipt of clinical effectiveness information from Royal Colleges or Professional Bodies which are not related to NICE should raise general awareness within their Division/Specialty areas and seek agreement on a local implementation process. This process should include the nomination of a clinical lead supported by the Clinical Director and should be subject to monitoring following changes in practice."
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.15,
                "text": "External Local Clinical Guidance"
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Not all aspects of healthcare have published clinical guidance and local initiatives and local healthcare professionals who are often in Local Clinical Networks can help to fill these gaps. Once local guidance has been approved and details published these will be disseminated in line with locally agreed protocol."
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clinicians  (or  equivalent  professionals)  in  receipt  of  locally  produced  clinical effectiveness  information  which  is  not  related  to  NICE  should  raise  general awareness within their Division/Specialty areas and seek agreement on a local implementation process. This process should include the nomination of a clinical lead supported by the Clinical Director and should be subject to monitoring following changes in practice."
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Training requirements"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "No specific training requirements."
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Monitoring and audit"
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Outlined  below  is  the  Trust's  process  of  monitoring  compliance  with,  and  the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "type": "table",
            "sequence_num": 170,
            "data": {
                "num_rows": 5,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "a) Process for identifying relevant documents"
                    },
                    {
                        "text": "Review"
                    },
                    {
                        "text": "Clinical Effectivenes s"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "NICE Implementation Group Clinical Audit & Effectiveness Group"
                    },
                    {
                        "text": "NICE Implementation Group Clinical Audit & Effectiveness Group"
                    },
                    {
                        "text": "b) Process for conducting an organisational gap analysis and identifying shortfalls"
                    },
                    {
                        "text": "Review"
                    },
                    {
                        "text": "Clinical Effectivenes s"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "Divisional Clinical Governance Groups NICE Implementation Group Clinical Audit & Effectiveness Group"
                    },
                    {
                        "text": "NICE Implementation Group Clinical Audit & Effectiveness Group"
                    },
                    {
                        "text": "c) Process for ensuring that recommendatio ns are acted upon throughout the organisation"
                    },
                    {
                        "text": "Review"
                    },
                    {
                        "text": "Clinical Effectivenes s"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "Divisional Clinical Governance Groups NICE Implementation Group Clinical Audit & Effectiveness Group"
                    },
                    {
                        "text": "NICE Implementation Group Clinical Audit & Effectiveness Group"
                    },
                    {
                        "text": "d) Process for documenting any decision not to implement NICE recommendatio ns"
                    },
                    {
                        "text": "Review"
                    },
                    {
                        "text": "Clinical Effectivenes s"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "Divisional Clinical Governance Groups NICE Implementation Group Clinical Audit & Effectiveness Group"
                    },
                    {
                        "text": "NICE Implementation Group Clinical Audit & Effectiveness Group"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Approval and implementation"
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "This policy will be approved by the Clinical Audit and Effectiveness Group which is the specialist group with the authority to approve local policies. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "The document will be made available on the staff intranet."
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Equality impact assessment"
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 2)"
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 0,
                "text": "High quality care for all: NHS Next Stage Review Final Report; Darzi, A (2008); Department of Health and Social Care. Available from: https://www.gov.uk/government/publications/high-quality-care-for-all-nhs-next- stage-review-final-report"
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 0,
                "text": "MBRRACE-UK: Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK: available from: https://www.npeu.ox.ac.uk/mbrrace-uk"
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Confidential Enquires into Patient Outcome and Death: available from https://www.ncepod.org.uk"
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Confidential Inquiry into Suicide and Safety in Mental Health;"
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The University of Manchester. Available from: https://sites.manchester.ac.uk/ncish NHS Executive. Promoting Clinical Effectiveness. A Framework for Action in and through the NHS. Leeds: Department of Health, 1996."
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Principles for putting evidence-based guidance into practice (2018); National Institute for Health and Care Excellence (NICE). Available from: https://intopractice.nice.org.uk/principles-putting-evidence-based-guidance-into- practice/index.html"
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Practical steps to improving the quality of care and services using NICE guidance (2018); National Institute for Health and Care Excellence (NICE). Available from: https://intopractice.nice.org.uk/practical-steps-improving-quality-of-care-services- using-nice-guidance/index.html"
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The NHS Constitution for England (2021); Department of Health and Social Care. Available from:  https://www.gov.uk/government/publications/the-nhs-constitution- for-england/the-nhs-constitution-for-england"
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The guide to the processes of technology appraisal (2014); National Institute for Health and Care Excellence (NICE). Available from: https://www.nice.org.uk/process/pmg19"
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The principles that guide the development of NICE guidance and standards; National Institute for Health and Care Excellence (NICE). Available from: https://www.nice.org.uk/about/who-we-are/our-principles"
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 1,
                "text": "APPENDIX 1: implementation flow chart for nice guidelines and quality standards"
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Horizon  Report to NIG NG/QS due to Scanning  be published in the following 3"
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "type": "image",
            "sequence_num": 190,
            "data": {
                "url": "MSEPO-21124 Clinical effectiveness policy 1.0.003.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "months"
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Is NG/QS  Email sent to relevant Divisional No further  No  relevant to  Clinical Lead for comments and"
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 1,
                "text": "action  the Trust?  the nomination of a clinician to needed  lead on implementation. Follow up"
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 0,
                "text": "if no reply within 1 month"
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 0,
                "text": "\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026"
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Yes"
            },
            "type": "ListItem",
            "sequence_num": 196
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Document in Trust NICE  NG/QS  Advertise on intranet Database and report at  published by"
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "data": {
                "is_heading": 0,
                "text": "next NIG  NICE"
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Baseline assessment template sent to Divisional Clinical Lead or previously nominated Implementation lead with request to complete the baseline assessment"
            },
            "type": "ListItem",
            "sequence_num": 199
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Reminder sent and"
            },
            "type": "ListItem",
            "sequence_num": 200
        },
        {
            "data": {
                "is_heading": 1,
                "text": "copied to Divisional"
            },
            "type": "ListItem",
            "sequence_num": 201
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Lead and Service  No  Completed baseline Manager. Escalate to  assessment received Trust Lead for Clinical  by CEU within 3 Effectiveness if no  months of publication"
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 1,
                "text": "reply received after"
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "nd reminder sent in 1"
            },
            "type": "ListItem",
            "sequence_num": 204
        },
        {
            "data": {
                "is_heading": 1,
                "text": "month  Yes"
            },
            "type": "ListItem",
            "sequence_num": 205
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Update Implementation status in CEU"
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 1,
                "text": "No  Yes  records, traffic light accordingly and report any exceptions to NIG. Implementation plan"
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Reply  sent to Divisional Clinical Lead and Service"
            },
            "type": "ListItem",
            "sequence_num": 208
        },
        {
            "data": {
                "is_heading": 1,
                "text": "received  Manager for Divisional agreement"
            },
            "type": "ListItem",
            "sequence_num": 209
        },
        {
            "data": {
                "is_heading": 1,
                "text": "within 1"
            },
            "type": "ListItem",
            "sequence_num": 210
        },
        {
            "data": {
                "is_heading": 1,
                "text": "No"
            },
            "type": "ListItem",
            "sequence_num": 211
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Are there any"
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 1,
                "text": "gaps in  Update status compliance?  in CEU"
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "data": {
                "is_heading": 1,
                "text": "records"
            },
            "type": "ListItem",
            "sequence_num": 214
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Yes"
            },
            "type": "ListItem",
            "sequence_num": 215
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Division to complete Are there any NICE  Yes  risk assessment and recommendations  include in Divisional"
            },
            "type": "ListItem",
            "sequence_num": 216
        },
        {
            "data": {
                "is_heading": 1,
                "text": "During  that will not be  Risk Register and Implementation  followed?  report to NIG period, CEU"
            },
            "type": "ListItem",
            "sequence_num": 217
        },
        {
            "data": {
                "is_heading": 1,
                "text": "request an  No"
            },
            "type": "ListItem",
            "sequence_num": 218
        },
        {
            "data": {
                "is_heading": 1,
                "text": "update on the"
            },
            "type": "ListItem",
            "sequence_num": 219
        },
        {
            "data": {
                "is_heading": 1,
                "text": "implementation"
            },
            "type": "ListItem",
            "sequence_num": 220
        },
        {
            "data": {
                "is_heading": 1,
                "text": "plan every 6  Implementation plan developed and status reported in"
            },
            "type": "ListItem",
            "sequence_num": 221
        },
        {
            "data": {
                "is_heading": 1,
                "text": "months  quarterly reports to Divisions for monitoring by Clinical"
            },
            "type": "ListItem",
            "sequence_num": 222
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Governance groups. Any exceptions are reported to NIG"
            },
            "type": "ListItem",
            "sequence_num": 223
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clinical Effectiveness Policy / MSEPO-21124/1.0"
            },
            "type": "ListItem",
            "sequence_num": 224
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 225
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clinical Effectiveness Policy / MSEPO-21124/1.0"
            },
            "type": "ListItem",
            "sequence_num": 226
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix2: Preliminary equality analysis"
            },
            "type": "ListItem",
            "sequence_num": 227
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Clinical Effectiveness Policy: (Please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 228
        },
        {
            "type": "table",
            "sequence_num": 229,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 230,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "To enable adoption of a Trustwide policy for clinical effectiveness activity"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "To ensure a consistent approach across the MSE for best practice guidance to be implemented and monitored"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients, staff and the organisation by implementing evidence based guidance"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 231,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Manori Jayasekera"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "NICE Guidance and National Audit Facilitator"
                    },
                    {
                        "text": "23 June 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 232
        }
    ]
}